ArticleJournal for immunotherapy of cancer2017

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.

Rajeev Shrimali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.